Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportRadiopharmaceutical Chemistry: Radiopharmacy

The development of automated Yttrium-86 processing at Washington University

Maiko Kume, Paul Carey, Suzanne Lapi and Michael Welch
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1545;
Maiko Kume
1Mallinckrodt Institute of Radiology, Divison of Radiological Sciences, Washington University School of Medicine, Saint Louis, MO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Carey
1Mallinckrodt Institute of Radiology, Divison of Radiological Sciences, Washington University School of Medicine, Saint Louis, MO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Suzanne Lapi
1Mallinckrodt Institute of Radiology, Divison of Radiological Sciences, Washington University School of Medicine, Saint Louis, MO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Welch
1Mallinckrodt Institute of Radiology, Divison of Radiological Sciences, Washington University School of Medicine, Saint Louis, MO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1545

Objectives Yttrium-86 (t1/2 = 14.74 h, 32% β+) has the potential to be useful in evaluating 90Y-labelled radiopharmaceuticals as a positron-emitting analog. However, with its high energy positron and gamma ray emissions, processing of useful amounts 86Y needs to be performed remotely in a hot cell to minimize radiation dose to personnel.

Methods Enriched 86SrCO3 powder was pressed onto a platinum disk and irradiated with 15 MeV protons on a cyclotron to produce 86Y via the (p,n) pathway. The irradiated target material was dissolved in 6M HCl, and separated into Sr(OH)2 and Y(OH)3 via filtration as reported by Avila-Rodriguez (Appl. Radiat. Isot. 2008). The recovered 86Y was evaporated to dryness and reconstituted for subsequent radiolabeling. The flow in the system was controlled through a series of inert diaphragm valves and a vacuum. The components within the system were controlled using TTL digital I/O modules. Direct manual handling of activity was only necessary during target introduction and 86Y activity recovery.

Results The majority of initial activity was recovered after the processing. The recovered activity had high radionuclidic purity.

Conclusions It is possible to construct a module in-house to process 86Y. The commercial availability of the components and the simplicity of the control system make it possible to adapt this technology to the processing of other non-standard radionuclides. Ongoing efforts are being made to improve target integrity on the cyclotron and to minimize losses during activity transfers.

Research Support This work was supported by NIH/NCI Grant R24 CA086307 “Radionuclide Resource for Cancer Applications.\#8221;

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 51, Issue supplement 2
May 2010
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The development of automated Yttrium-86 processing at Washington University
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
The development of automated Yttrium-86 processing at Washington University
Maiko Kume, Paul Carey, Suzanne Lapi, Michael Welch
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1545;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The development of automated Yttrium-86 processing at Washington University
Maiko Kume, Paul Carey, Suzanne Lapi, Michael Welch
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1545;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Radiopharmaceutical Chemistry: Radiopharmacy

  • Automated manufacturing of clinical-grade 177Lu- labeling DOTA0-Tyr3-octreotate using SmarTrace
  • The production of high specific activity Cu-64 as measured by ion chromatography
  • Ethanol and LPS stimulation of 18F FHBG uptake by lung and heart of NF Kappa B TK transgenic mice
Show more Radiopharmaceutical Chemistry: Radiopharmacy

Radiopharmacy Posters

  • Automated manufacturing of clinical-grade 177Lu- labeling DOTA0-Tyr3-octreotate using SmarTrace
  • The production of high specific activity Cu-64 as measured by ion chromatography
  • Ethanol and LPS stimulation of 18F FHBG uptake by lung and heart of NF Kappa B TK transgenic mice
Show more Radiopharmacy Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire